UTRS — Minerva Surgical Cashflow Statement
0.000.00%
Last trade - 00:00- $0.11m
- $28.52m
- $50.29m
Annual cashflow statement for Minerva Surgical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -52 | -18.3 | -21.5 | -34.1 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 32.7 | 1.94 | -2.99 | -1.21 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -2.11 | -2.87 | -8.55 | -11.1 |
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -19.8 | -12.2 | -22.4 | -35.6 |
| Capital Expenditures | -0.223 | -0.453 | -0.584 | -0.073 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | -15 | 0 | — |
| Acquisition of Business | ||||
| Cash from Investing Activities | -0.223 | -15.5 | -0.584 | -0.073 |
| Financing Cash Flow Items | -0.764 | 0 | -28.7 | -5 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 43.2 | 18.1 | 46.2 | -4.96 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 23.1 | -9.62 | 23.2 | -40.6 |